Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Obesity in adults" and "Society guideline links: Obesity in children" and "Society guideline links: Cirrhosis".)
International
●World Gastroenterology Organization (WGO): Global guidelines on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (2012)
Canada
●Expert Committee on NAFLD (ECON) and North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN): Clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children (2017)
United States
●American Association for Study of Liver Disease (AASLD), Asociación Latinoamericana para el Estudio del Hígado (ALEH), and the European Association for Study of the Liver (EASL): A multi-society Delphi consensus statement on new fatty liver disease nomenclature (2023)
●AASLD: Practice guidance for the clinical assessment and management of nonalcoholic fatty liver disease (2023)
●American Association of Clinical Endocrinology (AACE) and AASLD: Clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings (2022)
●American Gastroenterological Association (AGA): Clinical practice update on the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) in lean individuals (2022)
●AGA: Clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease (NAFLD) (2020)
●AGA: Clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease (2020)
●American College of Radiology (ACR): ACR Appropriateness Criteria chronic liver disease (revised 2019)
●Expert Committee on NAFLD (ECON) and North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN): Clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children (2017)
●AGA: Guideline for the diagnosis and management of non-alcoholic fatty liver disease (NAFLD) (2012)
Europe
●American Association for Study of Liver Disease (AASLD), Asociación Latinoamericana para el Estudio del Hígado (ALEH), and the European Association for Study of the Liver (EASL): A multi-society Delphi consensus statement on new fatty liver disease nomenclature (2023)
●EASL: Clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis, update (2021)
●European Society for Clinical Nutrition and Metabolism (ESPEN): Practical guideline – Clinical nutrition in liver disease (2020)
●ESPEN: Guideline on clinical nutrition in liver disease (2019)
●EASL-European Association for the Study of Diabetes (EASD)-European Association for the Study of Obesity (EASO): Clinical practice guidelines for the management of non-alcoholic fatty liver disease (2016)
●European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN): Position paper on the diagnosis of nonalcoholic fatty liver disease in children and adolescents (2012)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Diagnostics guidance on MRI-based technologies for assessing non-alcoholic fatty liver disease (2023)
●NICE: Guideline on non-alcoholic fatty liver disease (NAFLD) – Assessment and management (2016)
India
●Indian National Association for Study of the Liver (INASL): Guidance paper on nomenclature, diagnosis, and treatment of nonalcoholic fatty liver disease (NAFLD) (2022)
Japan
●[In English] Japanese Society of Gastroenterology (JSGE) and Japan Society Hepatology (JSH): Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 (published 2021)
●[In Japanese] JSGE: Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, 2nd edition (2020)
